000861622 001__ 861622
000861622 005__ 20230217124246.0
000861622 037__ $$aFZJ-2019-02068
000861622 082__ $$a570
000861622 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0
000861622 245__ $$aApplications of PET imaging of neurological tumors with radiolabeled amino acids
000861622 260__ $$aTorino$$bEd. Minerva Medica$$c2015
000861622 3367_ $$2DRIVER$$aarticle
000861622 3367_ $$2DataCite$$aOutput Types/Journal article
000861622 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1553602876_27369
000861622 3367_ $$2BibTeX$$aARTICLE
000861622 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000861622 3367_ $$00$$2EndNote$$aJournal Article
000861622 520__ $$aRoutine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced magnetic resonance imaging (MRI). However, the capacity of structural MRI to differentiate neoplastic tissue from non-specific treatment changes may be limited especially after therapeutic interventions such as neurosurgical resection, radio- and chemotherapy. Metabolic imaging using PET may provide relevant additional information on tumor metabolism, which allows for more accurate diagnostics especially in clinically equivocal situations. In contrast to the widely used ¹⁸F-2-fluoro-2-deoxy-D-glucose, which exhibits a poor tumor-to-background contrast within the brain, amino acid tracers provide high sensitivity to detect primary tumors, recurrent or residual gliomas, including most low-grade gliomas. The method improves targeting of biopsy and provides additional information of tumor extent, which is helpful for planning neurosurgery and radiotherapy. In the further course of the disease, amino acid positron-emission tomography (PET) allows a sensitive monitoring of treatment response, the early detection of tumor recurrence, and an improved differentiation of tumor recurrence from treatment-related changes. In the past, the method had only limited availability due to the use of radiopharmaceuticals with a short half-life. In recent years, however, novel amino acid tracers labeled with positron emitters with a longer half-life have been developed and clinically validated which allow a more efficient and cost-effective application. These developments and the well-documented diagnostic performance of PET using radiolabeled amino acids suggest that its application continues to spread and that the method may be available as a routine diagnostic technique for certain indications in the near future.
000861622 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000861622 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b1$$eCorresponding author
000861622 773__ $$0PERI:(DE-600)2083933-9$$n1$$p70-82$$tThe quarterly journal of nuclear medicine and molecular imaging$$v59$$x0392-0208$$y2015
000861622 909CO $$ooai:juser.fz-juelich.de:861622$$pVDB
000861622 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000861622 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b1$$kFZJ
000861622 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000861622 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000861622 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000861622 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bQ J NUCL MED MOL IM : 2015
000861622 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000861622 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000861622 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000861622 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000861622 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000861622 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000861622 920__ $$lyes
000861622 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000861622 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000861622 980__ $$ajournal
000861622 980__ $$aVDB
000861622 980__ $$aI:(DE-Juel1)INM-3-20090406
000861622 980__ $$aI:(DE-Juel1)INM-4-20090406
000861622 980__ $$aUNRESTRICTED